GLP-1 Loading During Elective Percutaneous Coronary Intervention

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 193 participants.

Also called NCT02127996

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 193 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02127996
Other papers using this trial's data
  • The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial American heart journal, 2019-09 DOI, PubMed 31277053

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02127996. Randomized; quadruple masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2017-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GLP-1 Loading During Elective Percutaneous Coronary Intervention
Acronym
GOLD-PCI
Condition
Angina Pectoris
Condition
Reperfusion Injury
Condition
Coronary Heart Disease
Intervention (Drug)
GLP-1
Intervention (Drug)
placebo
Lead sponsor
Papworth Hospital NHS Foundation Trust (class: other government)

Record details

Record id
cardio:ct-nct02127996
Content hash
9724fdcf100addb7cb4957f5f1204dfb441ad0c0d055b52c2e1615cea24acf1d